APA

Schmidt C., Ahmad T., Tulassay Z., Baumgart D. C., Bokemeyer B., Howaldt S., Stallmach A. & Büning C. (20170907). Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. : Alimentary pharmacology & therapeutics.

Chicago

Schmidt C, Ahmad T, Tulassay Z, Baumgart D C, Bokemeyer B, Howaldt S, Stallmach A and Büning C. 20170907. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. : Alimentary pharmacology & therapeutics.

Harvard

Schmidt C., Ahmad T., Tulassay Z., Baumgart D. C., Bokemeyer B., Howaldt S., Stallmach A. and Büning C. (20170907). Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. : Alimentary pharmacology & therapeutics.

MLA

Schmidt C, Ahmad T, Tulassay Z, Baumgart D C, Bokemeyer B, Howaldt S, Stallmach A and Büning C. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. : Alimentary pharmacology & therapeutics. 20170907.